Literature DB >> 8393410

Virus-induced airway hyperresponsiveness in man.

P J Sterk1.   

Abstract

Airway hyperresponsiveness is the most prominent functional abnormality in asthma. Although its aetiology is still unclear, it is well-known that allergen exposure and virus infections can temporarily induce or aggravate airway hyperresponsiveness. Among these environmental factors, virus infections appear to be clinically most relevant, since recent epidemiological studies have shown that most asthma exacerbations in children are associated with positive nasopharyngeal viral identification. The pathogenesis of virus-induced airway hyperresponsiveness has been investigated by experimental virus infections in animals and in man. Intranasal inoculation and/or inhalation of live attenuated influenza virus, or certain strains of rhinovirus, have been shown to induce airway hyperresponsiveness to various bronchoconstrictor stimuli in man. This indicates that experimental virus-infection, like allergen challenge, is an appropriate investigational model of asthma. The mechanisms of virus-induced airway hyperresponsiveness are still unclear, but may, in part, be similar to those involved in the pathogenesis of asthma. Currently investigated hypothesis include: epithelial damage or dysfunction, immunological responses, inflammatory mediator release, cholinergic and/or noncholinergic reflexes, and impaired beta-adrenoceptor function. Careful experimental studies, using modern laboratory techniques, are needed to unravel the role of viruses in the development of airway hyperresponsiveness. The results of such studies can potentially lead to an improvement of future asthma management.

Entities:  

Mesh:

Year:  1993        PMID: 8393410

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  9 in total

1.  Impact of severe acute respiratory syndrome (SARS) on pulmonary function, functional capacity and quality of life in a cohort of survivors.

Authors:  D S Hui; G M Joynt; K T Wong; C D Gomersall; T S Li; G Antonio; F W Ko; M C Chan; D P Chan; M W Tong; T H Rainer; A T Ahuja; C S Cockram; J J Y Sung
Journal:  Thorax       Date:  2005-05       Impact factor: 9.139

Review 2.  Association of rhinovirus infections with asthma.

Authors:  J E Gern; W W Busse
Journal:  Clin Microbiol Rev       Date:  1999-01       Impact factor: 26.132

3.  Selective targeting of TGF-β activation to treat fibroinflammatory airway disease.

Authors:  Shunsuke Minagawa; Jianlong Lou; Robert I Seed; Anthony Cormier; Shenping Wu; Yifan Cheng; Lynne Murray; Ping Tsui; Jane Connor; Ronald Herbst; Cedric Govaerts; Tyren Barker; Stephanie Cambier; Haruhiko Yanagisawa; Amanda Goodsell; Mitsuo Hashimoto; Oliver J Brand; Ran Cheng; Royce Ma; Kate J McKnelly; Weihua Wen; Arthur Hill; David Jablons; Paul Wolters; Hideya Kitamura; Jun Araya; Andrea J Barczak; David J Erle; Louis F Reichardt; James D Marks; Jody L Baron; Stephen L Nishimura
Journal:  Sci Transl Med       Date:  2014-06-18       Impact factor: 17.956

4.  Persistent and compartmentalised disruption of dendritic cell subpopulations in the lung following influenza A virus infection.

Authors:  Deborah H Strickland; Vanessa Fear; Seth Shenton; Mathew E Wikstrom; Graeme Zosky; Alexander N Larcombe; Patrick G Holt; Cassandra Berry; Christophe von Garnier; Philip A Stumbles
Journal:  PLoS One       Date:  2014-11-14       Impact factor: 3.240

5.  Lung epithelial protein disulfide isomerase A3 (PDIA3) plays an important role in influenza infection, inflammation, and airway mechanics.

Authors:  Nicolas Chamberlain; Bethany R Korwin-Mihavics; Emily M Nakada; Sierra R Bruno; David E Heppner; David G Chapman; Sidra M Hoffman; Albert van der Vliet; Benjamin T Suratt; Oliver Dienz; John F Alcorn; Vikas Anathy
Journal:  Redox Biol       Date:  2019-01-29       Impact factor: 11.799

6.  Clinical features of Chlamydia pneumoniae acute respiratory infection.

Authors:  Francesco Blasi
Journal:  Clin Microbiol Infect       Date:  1996-03       Impact factor: 8.067

7.  Virus infection in exacerbations of chronic obstructive pulmonary disease requiring ventilation.

Authors:  Robert J Cameron; Deo de Wit; Toni N Welsh; John Ferguson; Terry V Grissell; Peter J Rye
Journal:  Intensive Care Med       Date:  2006-05-24       Impact factor: 17.440

8.  Infectious causes of chronic inflammatory diseases and cancer.

Authors:  G H Cassell
Journal:  Emerg Infect Dis       Date:  1998 Jul-Sep       Impact factor: 6.883

9.  BSACI guidelines for the management of allergic and non-allergic rhinitis.

Authors:  G K Scadding; S R Durham; R Mirakian; N S Jones; S C Leech; S Farooque; D Ryan; S M Walker; A T Clark; T A Dixon; S R A Jolles; N Siddique; P Cullinan; P H Howarth; S M Nasser
Journal:  Clin Exp Allergy       Date:  2008-01       Impact factor: 5.018

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.